These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis. O'Reilly D; Taylor L; el-Hadidy K; Jayson MI Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594 [TBL] [Abstract][Full Text] [Related]
4. Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma. Siegel RJ; O'Connor B; Mena I; Criley JM Am Heart J; 1984 Dec; 108(6):1469-76. PubMed ID: 6507243 [TBL] [Abstract][Full Text] [Related]
5. Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study. Mizuno R; Fujimoto S; Saito Y; Nakamura S Eur J Heart Fail; 2010 Mar; 12(3):268-75. PubMed ID: 20071354 [TBL] [Abstract][Full Text] [Related]
6. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711 [TBL] [Abstract][Full Text] [Related]
7. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis. Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388 [TBL] [Abstract][Full Text] [Related]
8. Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis. Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papamichael C; Moulopoulou D; Ziaga A; Kostamis P; Moulopoulos S Clin Exp Rheumatol; 1996; 14(4):421-4. PubMed ID: 8871843 [TBL] [Abstract][Full Text] [Related]
9. Alterations of glomerular filtration rate during cold exposure in progressive systemic sclerosis: measurement with technetium-99m DTPA. Yamauchi K; Arimori S Jpn J Med; 1990; 29(2):208-11. PubMed ID: 2232369 [TBL] [Abstract][Full Text] [Related]
10. [Effect of diltiazem on cold-induced left ventricular dysfunction in patients with systemic sclerosis]. Rey RH; Marrero G; Chwojnik A; Martínez Martínez JA; Maldonado Cocco J; Rodrigué S; Casabé H Medicina (B Aires); 1997; 57(1):47-51. PubMed ID: 9435369 [TBL] [Abstract][Full Text] [Related]
11. Reproducibility of cold provocation in patients with Raynaud's phenomenon. Wigley FM; Malamet R; Wise RA J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980 [TBL] [Abstract][Full Text] [Related]
12. Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects. Wollersheim H; Thien T; van 't Laar A J Clin Pharmacol; 1987 Nov; 27(11):907-13. PubMed ID: 3429697 [TBL] [Abstract][Full Text] [Related]
13. Reversible myocardial perfusion defects during cold challenge in scleroderma. Long A; Duffy G; Bresnihan B Br J Rheumatol; 1986 May; 25(2):158-61. PubMed ID: 3708232 [TBL] [Abstract][Full Text] [Related]
14. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis. Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495 [TBL] [Abstract][Full Text] [Related]
15. Effect of the cold pressor test on diffusing capacity. Comparison of normal subjects and those with Raynaud's disease and progressive systemic sclerosis. Miller MJ Chest; 1983 Sep; 84(3):264-6. PubMed ID: 6884100 [TBL] [Abstract][Full Text] [Related]
16. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon. Gastaud M; Dolisi C; Bermon S; Gaudin P; Defauw G; Ardisson JL Clin Exp Rheumatol; 1995; 13(5):617-21. PubMed ID: 8575140 [TBL] [Abstract][Full Text] [Related]
18. Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon. Hahn M; Hahn C; Jünger M; Steins A; Zuder D; Klyscz T; Büchtemann A; Rassner G; Blazek V Microvasc Res; 1999 Mar; 57(2):187-98. PubMed ID: 10049666 [TBL] [Abstract][Full Text] [Related]
19. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease. Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066 [TBL] [Abstract][Full Text] [Related]
20. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Alexander EL; Firestein GS; Weiss JL; Heuser RR; Leitl G; Wagner HN; Brinker JA; Ciuffo AA; Becker LC Ann Intern Med; 1986 Nov; 105(5):661-8. PubMed ID: 3767147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]